Deals of the Day: Jelly spreads more VC

Fitmob, a San Francisco-based mobile app for finding local exercise workouts, has raised $9.75 million in venture capital and venture debt funding. Backers include Mayfield Fund, Silicon Valley Bank and individual angels. www.fitmob.com 

iProf Learnings Solutions, an India-based digital education library, has raised $9.5 million in Series B funding. Hobsons PLC led the round, and was joined by return backers IDG Ventures India and Norwest Venture Partners. www.iprofindia.com

Cohera Medical Inc., a Pittsburgh-based developer of absorbable surgical adhesives and sealants, has raised $9.3 million in new Series D funding. No new investor information was disclosed. The company previously announced that it had raised $17 million in Series B funding from firms like Kern Whelan Capital. www.coheramedical.com

Jelly, the new social search app from Twitter co-founder Biz Stone, has raised an undisclosed amount of Series B funding. Greylock Partners led the round, and was joined by return backer Spark Capital. www.jelly.co

Whiteout Networks GmbH, a Munich-based developer of apps and cloud services for encrypted email communication, has raised an undisclosed amount of seed funding from High-Tech-Gründerfonds andBayernkapital. www.whiteout.io

Private Equity Deals

SunGard Data Systems Inc. announced that it will spin off its Availability Services business on a tax-free basis to existing shareholders, including its private equity owners. The deal is expected to close by the end of Q1. SunGard was acquired in 2005 by a private equity consortium that included Bain Capital, Blackstone Group, Goldman Sachs, KKR, Providence Equity Partners, Silver Lake and TPG Capital.www.sungard.com

Aqua Terra Water Management, a merchant operator of salt water disposal facilities, has acquired certain saltwater disposal assets from Ceiba Energy Services Inc. and Phyllis Disposal Ltd. No financial terms were disclosed for the deal, which helps Aqua Terra enter the Canadian Bakken. Aqua Terra is a portfolio company of Bregal Partners. www.bregalpartners.com

AVX Learning LLC, a portfolio company of Comvest Capital, has acquired Adayana Industry Group, an Indianapolis-based provider of organizational performance solutions. No financial terms were disclosed. www.adayana.com

The Carlyle Group has agreed to acquire a minority stake in Vogue International, a Tampa Bay, Fla.-based maker of Organix brand hair care products. No financial terms were disclosed.www.vogueintl.com

China Huarong Asset Management Co Ltd., a state-owned investment manager, is in talks with several private equity firms about a share sale that could raise more than $2 billion, according to Reuters. Suitors include Bain Capital, The Blackstone Group, BlackRock and KKR.www.chamc.com.cn

Crestview Partners and B-29 Investments have acquired a control stake in Texoma Transportation & Crude Marketing LLC, a provider of crude oil purchasing, gathering and transportation services to the oil and gas industry. The deal was done in conjunction with Texoma’s purchase of Edmond, Okla.-based CP Energy. No financial terms were disclosed. www.txtcm.com

Palladin Consumer Retail Partners has acquired KT Health LLC, a maker of kinesiology tape and related sports medicine products for the retail market. No financial terms were disclosed.www.pcrp.com

Pallet USA LLC, a portfolio company of Blackthorne Partners, has acquired most assets ofGoeman’s Wood Products Inc., a rival Milwaukee-area pallet operator. No financial terms were disclosed. www.palletusa.com

Rosser Capital Partners has acquired Hickory Tavern, a Charlotte, N.C.-based chain of casual dining restaurants. No financial terms were disclosed. Arlington Capital Advisors managed the process.www.thehickorytavern.com

Summit Materials has acquired both Alleyton Resource and its Colorado Gulf affiliate, which operates sand & gravel sites and ready-mix concrete plants. No financial terms were disclosed. Summit Materials was formed in 2009 by The Blackstone Group and Silverhawk Capital Partners.www.summit-materials.com

IPOs

Care.com, a Waltham, Mass.-based online care marketplace, raised $91 million in its IPO. The company priced 5.35 million shares at $17 per share (above $14-$16 range), for an initial market cap of approximately $554 million. It will trade on the NYSE under ticker symbol CRCM, while Morgan Stanley, J.P. Morgan and BofA Merrill Lynch served as lead underwriters. Care.com had raised around $111 million in VC funding from Matrix Partners (22.24% pre-IPO stake), Trinity Ventures (14.39%), NEA (10.21%), Institutional Venture Partners (10.21%) and USAA (9.29%). www.care.com 

Com Hem AB, a Swedish cable television and broadband operator, has held “preliminary talks” with sponsor BC Partners about an IPO, according to Bloomberg. www.comhem.se

Continental Building Products Inc., a Reston, Va.-based maker of gypsum wallboard and complementary finishing products, has set its IPO terms to 13.24 million shares being offered at between $16 and $18 per share. It would have an initial market cap of approximately $749 million, were it to price in the middle of its range. The company plans to trade on the NYSE under ticker symbol CBPX, with Citigroup and Credit Suisse to serve as co-lead underwriters. It reports $32 million of net income on $252 million in revenue for the first nine months of 2013, and is owned by Lone Star Funds.www.continental-bp.com

Eleven Biotherapeutics Inc., a Cambridge, Mass.-based developer of protein-based biotherapeutics, has set its IPO terms to 4.3 million shares being offered at between $13 and $15 per share. It would have an initial market cap of approximately $206 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol EBIO, with Citigroup, Cowen & Co. and Leerink Swann serving as lead underwriters. Shareholders include Third Rock Ventures (41.3% pre-IPO stake), Flagship Ventures (28.8%) and Jafco (18.4%).www.elevenbio.com

Genocea Biosciences, a Cambridge, Mass.-based developer of T-cell vaccines for infectious diseases, has set its IPO terms to 5.5 million shares being offered at between $12 and $14 per share. It would have an initial market cap of approximately $224 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol GNCA, with Citigroup and Cowen & Co. serving as co-lead underwriters. It has raised over $88 million in VC funding from Polaris Venture Partners (16.3% pre-IPO stake), Lux Ventures (14.8%), S.R. One Ltd. (13%), Johnson & Johnson Development Corp. (11.7%), CVF LLC (9.3%), Skyline Ventures (8.8%), Cycad Group (6.6%), Auriga Ventures (6.5%), The Bill & Melinda Gates Foundation (6.2%) and Morningside Ventures.www.genocea.com

Rice Energy, a Canonsburg, Penn.-based E&P company focused on the Marcellus Shale and the Utica Shale, raised $924 million in its IPO. The company priced 44 million shares at $21 per share (high end of $19-$21 range), for an initial market cap of around $2.7 billion. It plans to trade on the NYSE under ticker symbol RICE public offering on Tuesday for as much as $800 million of stock. The company plans to use the proceeds to finance drilling operations in the Marcellus and Utica shale plays. www.riceenergy.com

Semler Scientific, a Portland, Ore.-based developer of medical devices that measure arterial blood flow, has set its IPO terms to 1.15 million shares being offered at between $12 and $14 per share. It would have an initial market cap of approximately $62 million, were it to price in the middle of its range. The company plans to trade on the Nasdaq under ticker symbol SMLR, with Aegis Capital serving as sole underwriter. www.flochec.com

OTHER DEALS

Qualcomm Inc. (Nasdaq: QCOM) has agreed to acquire a patent portfolio from Hewlett-Packard(Nasdaq: HPQ), which includes around 1,400 granted U.S. patents and pending U.S. patent applications, plus another 1,000 granted and pending patent applications from other counties. No financial terms were disclosed. Read more at Fortune.com

Sanofi (Paris: SAN) CEO Chris Viehbacher yesterday indicated an interest in repurchasing L’Oreal‘s (Paris: OR) 9% stake in Sanofi, during an interview with Reuters. He referred to such a deal as “very accretive” for Sanofi, although acknowledged that L’Oreal has not offered to sell the shares. The stake is currently valued at around $9 billion. www.sanofi.com

Sign up for Dan Primack’s daily email newsletter on deals and deal-makers: GetTermSheet.com